WS
AGN.PRA

Wedbush Securities’s Allergan plc AGN.PRA Stock Holding History

Wedbush Securities’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-517
Closed -$303K – 926
2017
Q4 		$303K Sell
517
-1,766
-77% -$1.14M 0.04% 543
2017
Q3 		$1.68M Sell
2,283
-134
-6% -$111K 0.22% 95
2017
Q2 		$2.1M Sell
2,417
-18
-0.7% -$15.1K 0.27% 74
2017
Q1 		$2.07M Buy
2,435
+498
+26% +$413K 0.28% 67
2016
Q4 		$1.48M Sell
1,937
-261
-12% -$197K 0.22% 91
2016
Q3 		$1.81M Sell
2,198
-65
-3% -$56.2K 0.27% 69
2016
Q2 		$1.89M Buy
2,263
+963
+74% +$804K 0.31% 65
2016
Q1 		$1.2M Buy
1,300
+232
+22% +$222K 0.21% 108
2015
Q4 		$1.1M Buy
1,068
+803
+303% +$806K 0.2% 109
2015
Q3 		$250K Buy
+265
New +$276K 0.05% 448

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Wedbush Securities's AGN.PRA Position: Q1 2018 in Review

Wedbush Securities sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 517 shares — an estimated $303K sold.

Wedbush Securities first reported a position in AGN.PRA in Q3 2015 and held it in 10 quarters. The position peaked at $2.1M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Wedbush Securities reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Wedbush Securities sold 517 Allergan plc shares in Q1 2018, an estimated $303K.
  • Wedbush Securities first reported a position in Allergan plc in Q3 2015 and held it in 10 quarters.
  • Wedbush Securities's Allergan plc position peaked at $2.1M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Wedbush Securities's 13F filing for Q1 2018, filed 1 May 2018.